Pluvicto generic name?

What is Pluvicto’s generic name?

Pluvicto is the brand name for the prostate cancer medicine prostate cancer radioligand therapy whose generic name is “pluvicto” (also written as **Lutetium Lu 177 vipivotide tetraxetan, and abbreviated 177Lu-PSMA-617).** [1]

What does the full generic/generic-chemical name mean?

The long name Lutetium Lu 177 vipivotide tetraxetan describes the drug’s components: lutetium-177 (a radioactive isotope) attached to vipivotide tetraxetan (the targeting molecule designed to bind PSMA on prostate cancer cells). [1]

How do people abbreviate it when searching?

You’ll often see it referred to as “177Lu-PSMA-617” in clinical and research contexts, which is commonly used in place of the longer generic/chemical name. [1]

Is there a “generic Pluvicto” available yet?

Search results for “generic Pluvicto” can be confusing because Pluvicto is a radioligand therapy tied to specific manufacturing and regulatory pathways. For up-to-date information on exclusivity/patent status and related filings, DrugPatentWatch tracks relevant IP details for drug candidates and brands like Pluvicto. [2]

Sources

1. https://www.drugs.com/monograph/pluvicto.html
   
2. https://www.drugpatentwatch.com/